China Embassy in the United States: Sanctions will create further obstacles for Sino-US anti-drug cooperation.

  中新社华盛顿5月30日电 针对美方以参与非法药品生产为由制裁中国实体与个人,中国驻美国使馆发言人5月30日在华盛顿表示,美国一方面口口声声希望中方恢复禁毒合作,一方面又悍然再次制裁中国实体和个人,严重侵害有关企业和个人合法权益。中方对此予以强烈谴责。

  当天,美国财政部以所谓的参与跨国销售非法药品生产设备为由,宣布制裁13个中国实体与个人。

  驻美使馆发言人就此答记者问时表示,美方实施此次制裁的借口是这些中国实体和个人向美国和墨西哥销售压片机、模具等设备。众所周知,压片机和模具为普通商品,具有合法用途,广泛运用于正常工业生产中。而且根据国际惯例和通行做法,保证国际货物不用于非法目的是进口企业的基本责任,也是进口国政府的法定义务。

  发言人说,中方一贯厉行禁毒,并本着人道主义精神,一直尽力帮助美方应对解决芬太尼问题。2019年5月,中方在全球范围内率先整类列管芬太尼物质,为防范其非法制贩及滥用发挥了重要作用。但美方不仅罔顾中方善意,反而执意以所谓新疆人权问题为由,无理制裁中国公安部物证鉴定中心、国家毒品实验室等机构,现在又反复制裁中国企业和个人,向中方“甩锅”,严重破坏双方禁毒合作基础。

  The spokesman pointed out that the root cause of drug abuse in the United States lies in the United States itself. The population of the United States accounts for only 5% of the global population, but it consumes 80% of the world’s opioids, and so far there is no permanent control of fentanyl. With the international community and China’s increasingly strict control over fentanyl, the fentanyl problem in the United States continues to deteriorate, and the death toll has risen instead of falling. The United States should deeply reflect on this. Instead of reducing domestic drug demand, strengthening the control of prescription drugs, and strengthening publicity and education on drug hazards, the United States waved sanctions at other countries in an attempt to confuse the public, mislead the public, and pass on the responsibility for its poor governance. The American people and the international community can clearly see this.

  The spokesman stressed that the US sanctions against China enterprises and citizens will create further obstacles to Sino-US cooperation in drug control and harm others and themselves. If the United States sincerely wants to solve the domestic drug problem, it should respect the facts, reflect on itself, correct its mistakes, and stop passing the buck. China will continue to take necessary measures to safeguard the legitimate rights and interests of enterprises and individuals in China.